LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 45

Search options

  1. Article ; Online: Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs.

    Rouzer, Carol A / Marnett, Lawrence J

    Chemical reviews

    2020  Volume 120, Issue 15, Page(s) 7592–7641

    Abstract: Cyclooxgenases are key enzymes of lipid signaling. They carry out the first step in the production of prostaglandins, important mediators of inflammation, pain, cardiovascular disease, and cancer, and they are the molecular targets for nonsteroidal anti- ... ...

    Abstract Cyclooxgenases are key enzymes of lipid signaling. They carry out the first step in the production of prostaglandins, important mediators of inflammation, pain, cardiovascular disease, and cancer, and they are the molecular targets for nonsteroidal anti-inflammatory drugs, which are among the oldest and most chemically diverse set of drugs known. Homodimeric proteins that behave as allosterically modulated, functional heterodimers, the cyclooxygenases exhibit complex kinetic behavior, requiring peroxide-dependent activation and undergoing suicide inactivation. Due to their important physiological and pathophysiological roles and keen interest on the part of the pharmaceutical industry, the cyclooxygenases have been the focus of a vast array of structural studies, leading to the publication of over 80 crystal structures of the enzymes in complex with substrates or inhibitors supported by a wealth of functional data generated by site-directed mutation experiments. In this review, we explore the chemical biology of the cyclooxygenases through the lens of this wealth of structural and functional information. We identify key structural features of the cyclooxygenases, break down their active site into regional binding pockets to facilitate comparisons between structures, and explore similarities and differences in the binding modes of the wide variety of ligands (both substrates and inhibitors) that have been characterized in complex with the enzymes. Throughout, we correlate structure with function whenever possible. Finally, we summarize what can and cannot be learned from the currently available structural data and discuss the critical intriguing questions that remain despite the wealth of information that has been amassed in this field.
    MeSH term(s) Animals ; Anti-Inflammatory Agents, Non-Steroidal/chemistry ; Anti-Inflammatory Agents, Non-Steroidal/pharmacology ; Catalytic Domain ; Cyclooxygenase Inhibitors/chemistry ; Cyclooxygenase Inhibitors/pharmacology ; Humans ; Molecular Dynamics Simulation ; Prostaglandin-Endoperoxide Synthases/chemistry ; Prostaglandin-Endoperoxide Synthases/metabolism ; Structure-Activity Relationship ; Substrate Specificity
    Chemical Substances Anti-Inflammatory Agents, Non-Steroidal ; Cyclooxygenase Inhibitors ; Prostaglandin-Endoperoxide Synthases (EC 1.14.99.1)
    Language English
    Publishing date 2020-07-01
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 207949-5
    ISSN 1520-6890 ; 0009-2665
    ISSN (online) 1520-6890
    ISSN 0009-2665
    DOI 10.1021/acs.chemrev.0c00215
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article: Structural and Chemical Biology of the Interaction of Cyclooxygenase with Substrates and Non-Steroidal Anti-Inflammatory Drugs

    Rouzer, Carol A / Marnett, Lawrence J

    Chemical reviews. 2020 July 01, v. 120, no. 15

    2020  

    Abstract: Cyclooxgenases are key enzymes of lipid signaling. They carry out the first step in the production of prostaglandins, important mediators of inflammation, pain, cardiovascular disease, and cancer, and they are the molecular targets for nonsteroidal anti- ... ...

    Abstract Cyclooxgenases are key enzymes of lipid signaling. They carry out the first step in the production of prostaglandins, important mediators of inflammation, pain, cardiovascular disease, and cancer, and they are the molecular targets for nonsteroidal anti-inflammatory drugs, which are among the oldest and most chemically diverse set of drugs known. Homodimeric proteins that behave as allosterically modulated, functional heterodimers, the cyclooxygenases exhibit complex kinetic behavior, requiring peroxide-dependent activation and undergoing suicide inactivation. Due to their important physiological and pathophysiological roles and keen interest on the part of the pharmaceutical industry, the cyclooxygenases have been the focus of a vast array of structural studies, leading to the publication of over 80 crystal structures of the enzymes in complex with substrates or inhibitors supported by a wealth of functional data generated by site-directed mutation experiments. In this review, we explore the chemical biology of the cyclooxygenases through the lens of this wealth of structural and functional information. We identify key structural features of the cyclooxygenases, break down their active site into regional binding pockets to facilitate comparisons between structures, and explore similarities and differences in the binding modes of the wide variety of ligands (both substrates and inhibitors) that have been characterized in complex with the enzymes. Throughout, we correlate structure with function whenever possible. Finally, we summarize what can and cannot be learned from the currently available structural data and discuss the critical intriguing questions that remain despite the wealth of information that has been amassed in this field.
    Keywords active sites ; cardiovascular diseases ; enzyme inactivation ; inflammation ; ligands ; mutation ; pain ; pharmaceutical industry ; prostaglandin synthase ; prostaglandins
    Language English
    Dates of publication 2020-0701
    Size p. 7592-7641.
    Publishing place American Chemical Society
    Document type Article
    Note NAL-AP-2-clean
    ZDB-ID 207949-5
    ISSN 1520-6890 ; 0009-2665
    ISSN (online) 1520-6890
    ISSN 0009-2665
    DOI 10.1021/acs.chemrev.0c00215
    Database NAL-Catalogue (AGRICOLA)

    More links

    Kategorien

  3. Article ; Online: Ferroptosis Inhibitors Suppress Prostaglandin Synthesis in Lipopolysaccharide-Stimulated Macrophages.

    Aleem, Ansari M / Kang, Weixi / Lin, Shuyang / Milad, Matthew / Kingsley, Philip J / Crews, Brenda C / Uddin, Md Jashim / Rouzer, Carol A / Marnett, Lawrence J

    ACS chemical biology

    2023  Volume 18, Issue 2, Page(s) 404–418

    Abstract: Necrostatin-1 blocks ferroptosis via an unknown mechanism and necroptosis through inhibition of receptor-interacting protein kinase-1 (RIP1). We report that necrostatin-1 suppresses cyclooxygenase-2-dependent prostaglandin biosynthesis in ... ...

    Abstract Necrostatin-1 blocks ferroptosis via an unknown mechanism and necroptosis through inhibition of receptor-interacting protein kinase-1 (RIP1). We report that necrostatin-1 suppresses cyclooxygenase-2-dependent prostaglandin biosynthesis in lipopolysaccharide-treated RAW264.7 macrophages (IC
    MeSH term(s) Cyclooxygenase 2 ; Lipopolysaccharides/pharmacology ; Ferroptosis ; Peroxidases/metabolism ; Hydrogen Peroxide/metabolism ; Prostaglandins ; Macrophages/metabolism
    Chemical Substances Cyclooxygenase 2 (EC 1.14.99.1) ; Lipopolysaccharides ; Peroxidases (EC 1.11.1.-) ; Hydrogen Peroxide (BBX060AN9V) ; Prostaglandins
    Language English
    Publishing date 2023-01-13
    Publishing country United States
    Document type Journal Article
    ISSN 1554-8937
    ISSN (online) 1554-8937
    DOI 10.1021/acschembio.2c00869
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article: Aspects of Prostaglandin Glycerol Ester Biology.

    Kingsley, Philip J / Rouzer, Carol A / Morgan, Amanda J / Patel, Sachin / Marnett, Lawrence J

    Advances in experimental medicine and biology

    2019  Volume 1161, Page(s) 77–88

    Abstract: The Cyclooxygenase enzymes (COX-1 and COX-2) incorporate 2 molecules of ... ...

    Abstract The Cyclooxygenase enzymes (COX-1 and COX-2) incorporate 2 molecules of O
    MeSH term(s) Animals ; Arachidonic Acids/metabolism ; Cyclooxygenase 2/metabolism ; Endocannabinoids/metabolism ; Glycerides/metabolism ; Glyceryl Ethers/analysis ; Glyceryl Ethers/chemistry ; Glyceryl Ethers/metabolism ; Prostaglandins/analysis ; Prostaglandins/chemistry ; Prostaglandins/metabolism
    Chemical Substances Arachidonic Acids ; Endocannabinoids ; Glycerides ; Glyceryl Ethers ; Prostaglandins ; glyceryl 2-arachidonate (8D239QDW64) ; Cyclooxygenase 2 (EC 1.14.99.1)
    Language English
    Publishing date 2019-09-27
    Publishing country United States
    Document type Journal Article ; Review
    ISSN 2214-8019 ; 0065-2598
    ISSN (online) 2214-8019
    ISSN 0065-2598
    DOI 10.1007/978-3-030-21735-8_8
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Signal integration and information transfer in an allosterically regulated network.

    Shockley, Erin M / Rouzer, Carol A / Marnett, Lawrence J / Deeds, Eric J / Lopez, Carlos F

    NPJ systems biology and applications

    2019  Volume 5, Page(s) 23

    Abstract: A biological reaction network may serve multiple purposes, processing more than one input and impacting downstream processes via more than one output. These networks operate in a dynamic cellular environment in which the levels of network components may ... ...

    Abstract A biological reaction network may serve multiple purposes, processing more than one input and impacting downstream processes via more than one output. These networks operate in a dynamic cellular environment in which the levels of network components may change within cells and across cells. Recent evidence suggests that protein concentration variability could explain cell fate decisions. However, systems with multiple inputs, multiple outputs, and changing input concentrations have not been studied in detail due to their complexity. Here, we take a systems biochemistry approach, combining physiochemical modeling and information theory, to investigate how cyclooxygenase-2 (COX-2) processes simultaneous input signals within a complex interaction network. We find that changes in input levels affect the amount of information transmitted by the network, as does the correlation between those inputs. This, and the allosteric regulation of COX-2 by its substrates, allows it to act as a signal integrator that is most sensitive to changes in relative input levels.
    MeSH term(s) Algorithms ; Allosteric Regulation/physiology ; Computational Biology/methods ; Cyclooxygenase 2/genetics ; Cyclooxygenase 2/metabolism ; Cyclooxygenase 2/physiology ; Information Theory ; Kinetics ; Models, Biological ; Protein Interaction Maps/physiology ; Signal Transduction/physiology ; Systems Biology/methods
    Chemical Substances Cyclooxygenase 2 (EC 1.14.99.1)
    Language English
    Publishing date 2019-07-18
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ISSN 2056-7189
    ISSN (online) 2056-7189
    DOI 10.1038/s41540-019-0100-9
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Green tea gets molecular.

    Rouzer, Carol A / Marnett, Lawrence J

    Cancer prevention research (Philadelphia, Pa.)

    2011  Volume 4, Issue 9, Page(s) 1343–1345

    Abstract: Green tea and its major polyphenolic flavonoid, epigallocatechin gallate (EGCG), have been credited with cancer chemopreventive activity for many years; the mechanism for this activity, however, has remained obscure. Now, as reported in this issue of the ...

    Abstract Green tea and its major polyphenolic flavonoid, epigallocatechin gallate (EGCG), have been credited with cancer chemopreventive activity for many years; the mechanism for this activity, however, has remained obscure. Now, as reported in this issue of the journal (beginning on page 1366), Urusova and colleagues showed direct binding of EGCG to the peptidyl prolyl cis/trans isomerase Pin1, which inhibited Pin1 enzymatic activity. They showed that Pin1 expression is required for EGCG effects on cell growth, c-Jun activation, and transcription regulation mediated by NF-κB and activator protein-1. The data provide a glimpse of the mechanism of action of EGCG and set a new bar for the future study of natural products with chemopreventive activity.
    MeSH term(s) Animals ; Anticarcinogenic Agents/pharmacology ; Catechin/analogs & derivatives ; Catechin/pharmacology ; Fibroblasts/metabolism ; Humans ; JNK Mitogen-Activated Protein Kinases/metabolism ; Mice ; Mice, Knockout ; Models, Chemical ; NF-kappa B/metabolism ; NIMA-Interacting Peptidylprolyl Isomerase ; Neoplasms/drug therapy ; Peptidylprolyl Isomerase/antagonists & inhibitors ; Peptidylprolyl Isomerase/metabolism ; Tea ; Transcription Factor AP-1/metabolism ; Transcription, Genetic
    Chemical Substances Anticarcinogenic Agents ; NF-kappa B ; NIMA-Interacting Peptidylprolyl Isomerase ; Tea ; Transcription Factor AP-1 ; Catechin (8R1V1STN48) ; epigallocatechin gallate (BQM438CTEL) ; JNK Mitogen-Activated Protein Kinases (EC 2.7.11.24) ; PIN1 protein, human (EC 5.2.1.8) ; Peptidylprolyl Isomerase (EC 5.2.1.8) ; Pin1 protein, mouse (EC 5.2.1.8)
    Language English
    Publishing date 2011-09
    Publishing country United States
    Document type Journal Article
    ZDB-ID 2434717-6
    ISSN 1940-6215 ; 1940-6207
    ISSN (online) 1940-6215
    ISSN 1940-6207
    DOI 10.1158/1940-6207.CAPR-11-0372
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Endocannabinoid oxygenation by cyclooxygenases, lipoxygenases, and cytochromes P450: cross-talk between the eicosanoid and endocannabinoid signaling pathways.

    Rouzer, Carol A / Marnett, Lawrence J

    Chemical reviews

    2011  Volume 111, Issue 10, Page(s) 5899–5921

    MeSH term(s) Cannabinoid Receptor Modulators/metabolism ; Cytochrome P-450 Enzyme System/metabolism ; Eicosanoids/metabolism ; Endocannabinoids ; Lipoxygenase/metabolism ; Oxygen/metabolism ; Prostaglandin-Endoperoxide Synthases/metabolism
    Chemical Substances Cannabinoid Receptor Modulators ; Eicosanoids ; Endocannabinoids ; Cytochrome P-450 Enzyme System (9035-51-2) ; Lipoxygenase (EC 1.13.11.12) ; Prostaglandin-Endoperoxide Synthases (EC 1.14.99.1) ; Oxygen (S88TT14065)
    Language English
    Publishing date 2011-09-19
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 207949-5
    ISSN 1520-6890 ; 0009-2665
    ISSN (online) 1520-6890
    ISSN 0009-2665
    DOI 10.1021/cr2002799
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Oxicams, a class of nonsteroidal anti-inflammatory drugs and beyond.

    Xu, Shu / Rouzer, Carol A / Marnett, Lawrence J

    IUBMB life

    2014  Volume 66, Issue 12, Page(s) 803–811

    Abstract: Oxicams are a class of nonsteroidal anti-inflammatory drugs (NSAIDs) structurally related to the enolic acid class of 4-hydroxy-1,2-benzothiazine carboxamides. They are used clinically to treat both acute and chronic inflammation by inhibiting the ... ...

    Abstract Oxicams are a class of nonsteroidal anti-inflammatory drugs (NSAIDs) structurally related to the enolic acid class of 4-hydroxy-1,2-benzothiazine carboxamides. They are used clinically to treat both acute and chronic inflammation by inhibiting the activity of the two cyclooxygenase (COX) isoforms, COX-1 and COX-2. Oxicams are structurally distinct from all other NSAIDs, exhibiting a novel binding pose in the COX active site. The 4-hydroxyl group on the thiazine ring partners with Ser-530 via hydrogen bonding while two coordinated water molecules mediate a polar interaction between the oxicam and COX. The rotation of Leu-531 in the complex opens a new pocket, which is not used for binding other NSAIDs to the enzyme. This structure provides the basis for understanding documented structure-activity relationships within the oxicam class. In addition, from the oxicam template, a series of potent microsomal prostaglandin E synthase-1 (mPGES-1) inhibitors represents a new direction for drug development. Here, we review the major route of oxicam synthesis and structure-activity for COX inhibition, as well as recent advances in oxicam-mediated mPGES-1 inhibition.
    MeSH term(s) Anti-Inflammatory Agents, Non-Steroidal/therapeutic use ; Humans ; Inflammation/drug therapy ; Intramolecular Oxidoreductases/antagonists & inhibitors ; Piroxicam/analogs & derivatives ; Piroxicam/therapeutic use ; Prostaglandin-E Synthases ; Thiazines/therapeutic use ; Thiazoles/therapeutic use
    Chemical Substances Anti-Inflammatory Agents, Non-Steroidal ; Thiazines ; Thiazoles ; Piroxicam (13T4O6VMAM) ; isoxicam (8XU734C4NG) ; Intramolecular Oxidoreductases (EC 5.3.-) ; PTGES protein, human (EC 5.3.99.3) ; Prostaglandin-E Synthases (EC 5.3.99.3) ; meloxicam (VG2QF83CGL)
    Language English
    Publishing date 2014-12
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Review
    ZDB-ID 1492141-8
    ISSN 1521-6551 ; 1521-6543
    ISSN (online) 1521-6551
    ISSN 1521-6543
    DOI 10.1002/iub.1334
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Fluorescent indomethacin-dansyl conjugates utilize the membrane-binding domain of cyclooxygenase-2 to block the opening to the active site.

    Xu, Shu / Uddin, Md Jashim / Banerjee, Surajit / Duggan, Kelsey / Musee, Joel / Kiefer, James R / Ghebreselasie, Kebreab / Rouzer, Carol A / Marnett, Lawrence J

    The Journal of biological chemistry

    2019  Volume 294, Issue 22, Page(s) 8690–8698

    Abstract: Many indomethacin amides and esters are cyclooxygenase-2 (COX-2)-selective inhibitors, providing a framework for the design of COX-2-targeted imaging and cancer chemotherapeutic agents. Although previous studies have suggested that the amide or ester ... ...

    Abstract Many indomethacin amides and esters are cyclooxygenase-2 (COX-2)-selective inhibitors, providing a framework for the design of COX-2-targeted imaging and cancer chemotherapeutic agents. Although previous studies have suggested that the amide or ester moiety of these inhibitors binds in the lobby region, a spacious alcove within the enzyme's membrane-binding domain, structural details have been lacking. Here, we present observations on the crystal complexes of COX-2 with two indomethacin-dansyl conjugates (compounds 1 and 2) at 2.22-Å resolution. Both compounds are COX-2-selective inhibitors with IC
    MeSH term(s) Animals ; Catalytic Domain ; Cell Membrane/metabolism ; Cyclooxygenase 2/chemistry ; Cyclooxygenase 2/metabolism ; Cyclooxygenase 2 Inhibitors/chemistry ; Cyclooxygenase 2 Inhibitors/pharmacology ; Dansyl Compounds/chemistry ; Fluorescence ; Indomethacin/chemistry ; Inhibitory Concentration 50 ; Kinetics ; Mice ; Models, Molecular ; Time Factors
    Chemical Substances Cyclooxygenase 2 Inhibitors ; Dansyl Compounds ; Cyclooxygenase 2 (EC 1.14.99.1) ; Indomethacin (XXE1CET956)
    Language English
    Publishing date 2019-04-18
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2997-x
    ISSN 1083-351X ; 0021-9258
    ISSN (online) 1083-351X
    ISSN 0021-9258
    DOI 10.1074/jbc.RA119.007405
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: Erratum: Lysophospholipases cooperate to mediate lipid homeostasis and lysophospholipid signaling.

    Wepy, James A / Galligan, James J / Kingsley, Phillip J / Xu, Shu / Goodman, Michael C / Tallman, Keri A / Rouzer, Carol A / Marnett, Lawrence J

    Journal of lipid research

    2019  Volume 60, Issue 7, Page(s) 1345

    Language English
    Publishing date 2019-06-28
    Publishing country United States
    Document type Journal Article ; Published Erratum
    ZDB-ID 80154-9
    ISSN 1539-7262 ; 0022-2275
    ISSN (online) 1539-7262
    ISSN 0022-2275
    DOI 10.1194/jlr.ERR119000139
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top